- Home
- XPO vs WAT Comparison
XPO vs WAT Comparison
Compare XPO & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPO
- WAT
- Stock Information
- Founded
- XPO 2000
- WAT 1958
- Country
- XPO United States
- WAT United States
- Employees
- XPO N/A
- WAT N/A
- Industry
- XPO Transportation Services
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- XPO Consumer Discretionary
- WAT Industrials
- Exchange
- XPO Nasdaq
- WAT Nasdaq
- Market Cap
- XPO 16.0B
- WAT 17.4B
- IPO Year
- XPO N/A
- WAT 1995
- Fundamental
- Price
- XPO $134.08
- WAT $382.16
- Analyst Decision
- XPO Strong Buy
- WAT Buy
- Analyst Count
- XPO 18
- WAT 13
- Target Price
- XPO $145.61
- WAT $379.00
- AVG Volume (30 Days)
- XPO 1.4M
- WAT 652.9K
- Earning Date
- XPO 10-30-2025
- WAT 11-04-2025
- Dividend Yield
- XPO N/A
- WAT N/A
- EPS Growth
- XPO N/A
- WAT 3.82
- EPS
- XPO 2.78
- WAT 10.88
- Revenue
- XPO $8,068,000,000.00
- WAT $3,105,638,000.00
- Revenue This Year
- XPO $1.30
- WAT $7.12
- Revenue Next Year
- XPO $3.90
- WAT $6.22
- P/E Ratio
- XPO $48.11
- WAT $34.88
- Revenue Growth
- XPO N/A
- WAT 6.90
- 52 Week Low
- XPO $85.06
- WAT $275.05
- 52 Week High
- XPO $161.00
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- XPO 49.41
- WAT 69.65
- Support Level
- XPO $136.38
- WAT $340.09
- Resistance Level
- XPO $142.03
- WAT $391.79
- Average True Range (ATR)
- XPO 5.68
- WAT 10.91
- MACD
- XPO -0.08
- WAT 1.20
- Stochastic Oscillator
- XPO 54.69
- WAT 80.12
About XPO XPO Inc.
Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. We estimate LTL shipping makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.